Adults
Conditions
Interventions
Luconac solution 5% is applied to all toes. Single dose.
Clenafin solution 10% is applied to all toes. Single dose.
Sponsors
Medical Corporation Shinanokai Samoncho Clinic
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Adult male and female with healthy toes. 2.Those who have not medicated with topical antifungal drugs. 3.Those who have toes without inflammatory and external injury including nail trinea.
Exclusion criteria
Exclusion criteria: 1.Those who have malfunctions on fingers or upper limb that impede the embrocation action. 2.Those who have other diseases that may impede the embrocation action, such as visual handicapped except hypermetropia or neuropathy etc. 3.Those who have diseases that impede the informed concent or the operation of study, such as dementia. 4.Those who are during lactation, pregnancy or possible pregnancy. 5.Those who have history of hypersensitiveness on the study drugs. 6.Others who are deemed inappropriate by the investigator to conduct this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS of five assessements on the usability. | — |
Countries
Japan
Contacts
Public ContactSatoko Shimizu
Tokyo Research Center of Clinical Pharmacology Co., Ltd. Clinical trial promotion II dept.
Outcome results
None listed